Cargando…
Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson’s disease
BACKGROUND: Low-pass sequencing (LPS) has been extensively investigated for applicability to various genetic studies due to its advantages over genotype array data including cost-effectiveness. Predicting the risk of complex diseases such as Parkinson’s disease (PD) using polygenic risk score (PRS)...
Autores principales: | Kim, Sungjae, Shin, Jong-Yeon, Kwon, Nak-Jung, Kim, Chang-Uk, Kim, Changhoon, Lee, Chong Sik, Seo, Jeong-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403377/ https://www.ncbi.nlm.nih.gov/pubmed/34454617 http://dx.doi.org/10.1186/s40246-021-00357-w |
Ejemplares similares
-
ClinPharmSeq: A targeted sequencing panel for clinical pharmacogenetics implementation
por: Lee, Seung-been, et al.
Publicado: (2022) -
Estimating prevalence of human traits among populations from polygenic risk scores
por: Graham, Britney E., et al.
Publicado: (2021) -
Whole genome sequencing reveals a frameshift mutation and a large deletion in YY1AP1 in a girl with a panvascular artery disease
por: Raggio, Víctor, et al.
Publicado: (2021) -
Evaluation of optimal methods and ancestries for calculating polygenic risk scores in East Asian population
por: Kim, Dong Jun, et al.
Publicado: (2023) -
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types
por: Kim, Sungjae, et al.
Publicado: (2020)